| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10745019 | Parkinsonism & Related Disorders | 2015 | 39 Pages |
Abstract
This meta-analysis demonstrates that pharmacologic treatment with antidepressant medications, specifically the selective serotonin reuptake inhibitors (SSRIs), and behavioral interventions (CBT) significantly improved depression among Parkinson's disease patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Emily Bomasang-Layno, Iris Fadlon, Andrea N. Murray, Seth Himelhoch,